{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:05:25Z","timestamp":1780455925130,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05051-2","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:22:34Z","timestamp":1776673354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamics of IFN-\u03b3, IL-2, and IL-6 during early tuberculosis treatment: significant longitudinal changes but limited value as standalone discriminators of treatment status"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhan Qiu","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Mei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"5051_CR1","doi-asserted-by":"publisher","unstructured":"Isaiah AR, Williams M, Loots DT et al. Potential biomarkers for tuberculous meningitis diagnosis using metabolomics and proteomics: a systematic review. BMC Infect Dis. 2025;25(1):1298. https:\/\/doi.org\/10.1186\/s12879-025-11740-6. Published 14 Oct 2025.","DOI":"10.1186\/s12879-025-11740-6"},{"key":"5051_CR2","doi-asserted-by":"publisher","first-page":"127679","DOI":"10.1016\/j.vaccine.2025.127679","volume":"64","author":"G Nosan","year":"2025","unstructured":"Nosan G, Cerkvenik \u0160kafar A. Screen first, vaccinate later: Enhancing tuberculosis vaccination safety through newborn immunodeficiency screening. Vaccine. 2025;64:127679. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127679.","journal-title":"Vaccine"},{"key":"5051_CR3","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.jctube.2025.100510","volume":"38","author":"TK Suvvari","year":"2025","unstructured":"Suvvari TK. The persistent threat of tuberculosis - Why ending TB remains elusive? J Clin Tuberc Other Mycobact Dis. 2025;38:100510. https:\/\/doi.org\/10.1016\/j.jctube.2025.100510. Published 2025 Jan 6.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"6","key":"5051_CR4","doi-asserted-by":"publisher","first-page":"e903","DOI":"10.1016\/S2214-109X(23)00135-3","volume":"11","author":"T Broger","year":"2023","unstructured":"Broger T, Koeppel L, Huerga H, et al. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data. Lancet Glob Health. 2023;11(6):e903\u201316. https:\/\/doi.org\/10.1016\/S2214-109X(23)00135-3.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"5051_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7150\/ntno.95332","volume":"9","author":"P Sharma","year":"2025","unstructured":"Sharma P, Gupta RK, Aittan S, et al. Development and assessment of a novel magnetic nanoparticle antibody-conjugate and aptamer-based assay (MNp-Ab-Ap assay) for the rapid diagnosis of pleural tuberculosis. Nanotheranostics. 2025;9(1):20\u201330. https:\/\/doi.org\/10.7150\/ntno.95332. Published 2025 Jan 1.","journal-title":"Nanotheranostics"},{"issue":"22","key":"5051_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1055\/a-2502-6525","volume":"150","author":"E Terhalle","year":"2025","unstructured":"Terhalle E, Rademacher J. Nichttuberkul\u00f6se Mykobakterien: diagnostische Herausforderungen und individualisierte Therapieans\u00e4tze [Nontuberculous Mycobacteria: Diagnostic Challenges and Individualized Therapeutic Approaches]. Dtsch Med Wochenschr. 2025;150(22):1360\u20136. https:\/\/doi.org\/10.1055\/a-2502-6525.","journal-title":"Dtsch Med Wochenschr"},{"issue":"10","key":"5051_CR7","doi-asserted-by":"publisher","first-page":"e0096925","DOI":"10.1128\/spectrum.00969-25","volume":"13","author":"N Niemand","year":"2025","unstructured":"Niemand N, Rooney JA, Malatesta S, et al. Contamination rates in serially sampled sputum specimens obtained during tuberculosis treatment to capture culture conversion. Microbiol Spectr. 2025;13(10):e0096925. https:\/\/doi.org\/10.1128\/spectrum.00969-25.","journal-title":"Microbiol Spectr"},{"key":"5051_CR8","doi-asserted-by":"publisher","first-page":"1392256","DOI":"10.3389\/fimmu.2024.1392256","volume":"15","author":"AN Pandiarajan","year":"2024","unstructured":"Pandiarajan AN, Kumar NP, Selvaraj N, et al. Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis. Front Immunol. 2024;15:1392256. https:\/\/doi.org\/10.3389\/fimmu.2024.1392256. Published 2024 Jun 3.","journal-title":"Front Immunol"},{"issue":"1","key":"5051_CR9","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1186\/s12879-025-11869-4","volume":"25","author":"T Petsut","year":"2025","unstructured":"Petsut T, Piewluang S, Ngamskulrungroj P, Angkasekwinai N. Disseminated Mycobacterium avium complex infection presenting as superior vena cava syndrome in a patient with anti-interferon-gamma autoantibody: a case report. BMC Infect Dis. 2025;25(1):1483. https:\/\/doi.org\/10.1186\/s12879-025-11869-4. Published 2025 Nov 3.","journal-title":"BMC Infect Dis"},{"key":"5051_CR10","doi-asserted-by":"publisher","first-page":"114415","DOI":"10.1016\/j.intimp.2025.114415","volume":"152","author":"J Guo","year":"2025","unstructured":"Guo J, Jia Z, Yang Y, et al. Bioinformatics analysis, immunogenicity, and therapeutic efficacy evaluation of a novel multi-stage, multi-epitope DNA vaccine for tuberculosis. Int Immunopharmacol. 2025;152:114415. https:\/\/doi.org\/10.1016\/j.intimp.2025.114415.","journal-title":"Int Immunopharmacol"},{"key":"5051_CR11","doi-asserted-by":"publisher","first-page":"1601637","DOI":"10.3389\/fimmu.2025.1601637","volume":"16","author":"L Hao","year":"2025","unstructured":"Hao L, Imran QM, Ullah N. CD39 dynamics in tuberculosis: a potential biomarker of immune dysregulation and T cell exhaustion. Front Immunol. 2025;16:1601637. https:\/\/doi.org\/10.3389\/fimmu.2025.1601637. Published 2025 Aug 11.","journal-title":"Front Immunol"},{"issue":"12","key":"5051_CR12","doi-asserted-by":"publisher","first-page":"e20250460","DOI":"10.1084\/jem.20250460","volume":"222","author":"V Stetsenko","year":"2025","unstructured":"Stetsenko V, Gail DP, Reba SM, et al. Human CD4\u2009+\u2009T cells recognize Mycobacterium tuberculosis-infected macrophages amid broader responses. J Exp Med. 2025;222(12):e20250460. https:\/\/doi.org\/10.1084\/jem.20250460.","journal-title":"J Exp Med"},{"issue":"1","key":"5051_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13567-025-01634-5","volume":"56","author":"I Agull\u00f3-Ros","year":"2025","unstructured":"Agull\u00f3-Ros I, Mu\u00f1oz-Fern\u00e1ndez L, Roy \u00c1, et al. Protective effect of heat-inactivated Mycobacterium bovis applied intramuscularly is associated with enhanced lung immune response in caprine tuberculosis. Vet Res. 2025;56(1):209. https:\/\/doi.org\/10.1186\/s13567-025-01634-5. Published 2025 Nov 4.","journal-title":"Vet Res"},{"key":"5051_CR14","doi-asserted-by":"publisher","unstructured":"Lamba T, Prajapati S, Chowdhury A, Bandyopadhyay A, Agrewala JN. F18 Promiscuous epitope of Acr1 protein of mycobacterium tuberculosis induces the secretion of IL-10 and Tregs but not IL-6. Protein Pept Lett. https:\/\/doi.org\/10.2174\/0109298665398349250728195645.\u00a0 Published online 11 Aug 2025.","DOI":"10.2174\/0109298665398349250728195645"},{"issue":"5","key":"5051_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/antibiotics13050406","volume":"13","author":"M Tosi","year":"2024","unstructured":"Tosi M, Coloretti I, Meschiari M, De Biasi S, Girardis M, Busani S. The Interplay between Antibiotics and the Host Immune Response in Sepsis: From Basic Mechanisms to Clinical Considerations: A Comprehensive Narrative Review. Antibiot (Basel). 2024;13(5):406. https:\/\/doi.org\/10.3390\/antibiotics13050406. Published 2024 Apr 28.","journal-title":"Antibiot (Basel)"},{"issue":"3","key":"5051_CR16","doi-asserted-by":"publisher","first-page":"e71261","DOI":"10.1002\/alz.71261","volume":"22","author":"NS Carmichael","year":"2026","unstructured":"Carmichael NS, Deijnen HR, Wong SY, et al. Longitudinal plasma interleukin-6 and post-stroke cognitive outcomes: The Stroke-IMPaCT study. Alzheimers Dement. 2026;22(3):e71261. https:\/\/doi.org\/10.1002\/alz.71261.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"5051_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","volume":"57","author":"AN Shouse","year":"2024","unstructured":"Shouse AN, LaPorte KM, Malek TR. Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer. Immunity. 2024;57(3):414\u201328. https:\/\/doi.org\/10.1016\/j.immuni.2024.02.001.","journal-title":"Immunity"},{"issue":"8","key":"5051_CR18","doi-asserted-by":"publisher","first-page":"e0305158","DOI":"10.1371\/journal.pone.0305158","volume":"19","author":"M Krivo\u0161ov\u00e1","year":"2024","unstructured":"Krivo\u0161ov\u00e1 M, Doh\u00e1l M, M\u00e4siarov\u00e1 S, et al. Exploring cytokine dynamics in tuberculosis: A comparative analysis of patients and controls with insights from three-week antituberculosis intervention. PLoS ONE. 2024;19(8):e0305158. https:\/\/doi.org\/10.1371\/journal.pone.0305158. Published 2024 Aug 29.","journal-title":"PLoS ONE"},{"key":"5051_CR19","doi-asserted-by":"publisher","unstructured":"Lo CY, Huang YC, Huang HY et al. Increased Th1 cells with disease resolution of active pulmonary tuberculosis in non-atopic patients. Biomedicines. 2021;9(7):724. https:\/\/doi.org\/10.3390\/biomedicines9070724.\u00a0Published 24 Jun 2021.","DOI":"10.3390\/biomedicines9070724"},{"key":"5051_CR20","doi-asserted-by":"publisher","unstructured":"Fang Y, Tang Y, Luo QX et al. Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27-CD38\u2009+\u2009IFN-\u03b3\u2009+\u2009CD4\u2009+\u2009T cells before and after anti-tuberculosis treatment. Eur J Med Res. 2024;29(1):147. https:\/\/doi.org\/10.1186\/s40001-024-01713-x. Published 1 Mar 2024.","DOI":"10.1186\/s40001-024-01713-x"},{"key":"5051_CR21","doi-asserted-by":"publisher","unstructured":"Liao YX, Xia L, Liu P et al. Five CGD-Linked CYBB Mutations in Chinese patients: insights into predicting IFN-\u03b3 treatment efficacy. J Clin Immunol. 2025;45(1):131. https:\/\/doi.org\/10.1007\/s10875-025-01926-7.\u00a0Published 30 Sept 2025.","DOI":"10.1007\/s10875-025-01926-7"},{"issue":"8","key":"5051_CR22","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/s41590-024-01897-8","volume":"25","author":"M Sun","year":"2024","unstructured":"Sun M, Phan JM, Kieswetter NS, et al. Specific CD4\u2009+\u2009T cell phenotypes associate with bacterial control in people who \u2018resist\u2019 infection with Mycobacterium tuberculosis. Nat Immunol. 2024;25(8):1411\u201321. https:\/\/doi.org\/10.1038\/s41590-024-01897-8.","journal-title":"Nat Immunol"},{"key":"5051_CR23","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.2147\/COPD.S434601","volume":"18","author":"M Jiang","year":"2023","unstructured":"Jiang M, Pang N, Wang J, et al. Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2023;18:2867\u201386. https:\/\/doi.org\/10.2147\/COPD.S434601. Published 2023 Dec 5.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"5051_CR24","doi-asserted-by":"publisher","first-page":"106173","DOI":"10.1016\/j.jinf.2024.106173","volume":"89","author":"H Mutavhatsindi","year":"2024","unstructured":"Mutavhatsindi H, Manyelo CM, Snyders CI, et al. Baseline and end-of-treatment host serum biomarkers predict relapse in adults with pulmonary tuberculosis. J Infect. 2024;89(1):106173. https:\/\/doi.org\/10.1016\/j.jinf.2024.106173.","journal-title":"J Infect"},{"issue":"1","key":"5051_CR25","doi-asserted-by":"publisher","first-page":"100922","DOI":"10.1016\/S2666-5247(24)00162-9","volume":"6","author":"F Hamilton","year":"2025","unstructured":"Hamilton F, Schurz H, Yates TA, et al. Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study. Lancet Microbe. 2025;6(1):100922. https:\/\/doi.org\/10.1016\/S2666-5247(24)00162-9.","journal-title":"Lancet Microbe"},{"issue":"7","key":"5051_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1615\/CritRevEukaryotGeneExpr.2025059856","volume":"35","author":"W Ma","year":"2025","unstructured":"Ma W, Zhang S, Xu L, Dong Y. Screening of miRNAs Characterizing Spinal Tuberculosis and Construction of Its Regulatory Network. Crit Rev Eukaryot Gene Expr. 2025;35(7):65\u201379. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2025059856.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"4","key":"5051_CR27","doi-asserted-by":"publisher","first-page":"e0316648","DOI":"10.1371\/journal.pone.0316648","volume":"20","author":"K Meserve","year":"2025","unstructured":"Meserve K, Chapman CA, Xu M, et al. Multiplexed cytokine profiling identifies diagnostic signatures for latent tuberculosis and reactivation risk stratification. PLoS ONE. 2025;20(4):e0316648. https:\/\/doi.org\/10.1371\/journal.pone.0316648. Published 2025 Apr 9.","journal-title":"PLoS ONE"},{"issue":"1","key":"5051_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12879-023-08943-0","volume":"24","author":"L Zhang","year":"2024","unstructured":"Zhang L, Yang Z, Wu F, et al. Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: an exploratory study. BMC Infect Dis. 2024;24(1):28. https:\/\/doi.org\/10.1186\/s12879-023-08943-0. Published 2024 Jan 2.","journal-title":"BMC Infect Dis"},{"key":"5051_CR29","doi-asserted-by":"publisher","unstructured":"Yasuda I, Saludar NRD, Sayo AR et al. Evaluation of cytokine profiles related to Mycobacterium tuberculosis latent antigens using a whole-blood assay in the Philippines. Front Immunol. 2024;15:1330796. https:\/\/doi.org\/10.3389\/fimmu.2024.1330796.\u00a0Published 10 Apr 2024.","DOI":"10.3389\/fimmu.2024.1330796"},{"issue":"11","key":"5051_CR30","doi-asserted-by":"publisher","first-page":"e0002327","DOI":"10.1371\/journal.pgph.0002327","volume":"3","author":"ST Selvavinayagam","year":"2023","unstructured":"Selvavinayagam ST, Aswathy B, Yong YK, et al. Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts-A cross-sectional study. PLOS Glob Public Health. 2023;3(11):e0002327. https:\/\/doi.org\/10.1371\/journal.pgph.0002327. Published 2023 Nov 22.","journal-title":"PLOS Glob Public Health"},{"issue":"1","key":"5051_CR31","doi-asserted-by":"publisher","first-page":"2386030","DOI":"10.1080\/07853890.2024.2386030","volume":"56","author":"S Leo","year":"2024","unstructured":"Leo S, Narasimhan M, Rathinam S, Banerjee A. Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review. Ann Med. 2024;56(1):2386030. https:\/\/doi.org\/10.1080\/07853890.2024.2386030.","journal-title":"Ann Med"},{"key":"5051_CR32","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.3389\/fmicb.2019.02789","volume":"10","author":"YK Yong","year":"2019","unstructured":"Yong YK, Tan HY, Saeidi A, et al. Immune Biomarkers for Diagnosis and Treatment Monitoring of Tuberculosis: Current Developments and Future Prospects. Front Microbiol. 2019;10:2789. https:\/\/doi.org\/10.3389\/fmicb.2019.02789. Published 2019 Dec 18.","journal-title":"Front Microbiol"},{"key":"5051_CR33","doi-asserted-by":"publisher","first-page":"1108155","DOI":"10.3389\/fcimb.2023.1108155","volume":"13","author":"VTA Thu","year":"2023","unstructured":"Thu VTA, Dat LD, Jayanti RP, et al. Advancing personalized medicine for tuberculosis through the application of immune profiling. Front Cell Infect Microbiol. 2023;13:1108155. https:\/\/doi.org\/10.3389\/fcimb.2023.1108155. Published 2023 Feb 10.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"5051_CR34","doi-asserted-by":"publisher","first-page":"13345","DOI":"10.1038\/s41598-024-63365-5","volume":"14","author":"L Li","year":"2024","unstructured":"Li L, Wang T, Chen Z, Liang J, Ding H. Multi-cohort analysis reveals immune subtypes and predictive biomarkers in tuberculosis. Sci Rep. 2024;14(1):13345. https:\/\/doi.org\/10.1038\/s41598-024-63365-5. Published 2024 Jun 10.","journal-title":"Sci Rep"},{"key":"5051_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tube.2018.08.011","volume":"114","author":"V Clifford","year":"2019","unstructured":"Clifford V, Tebruegge M, Zufferey C, et al. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting. Tuberculosis (Edinb). 2019;114:91\u2013102. https:\/\/doi.org\/10.1016\/j.tube.2018.08.011.","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"5051_CR36","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jinf.2020.09.032","volume":"81","author":"EL Sudbury","year":"2020","unstructured":"Sudbury EL, Clifford V, Messina NL, Song R, Curtis N. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review. J Infect. 2020;81(6):873\u201381. https:\/\/doi.org\/10.1016\/j.jinf.2020.09.032.","journal-title":"J Infect"},{"issue":"2","key":"5051_CR37","doi-asserted-by":"publisher","first-page":"111256","DOI":"10.1016\/j.humimm.2025.111256","volume":"86","author":"MI Al-Zubaidi","year":"2025","unstructured":"Al-Zubaidi MI, Lafi SA, Abdulateef YM. Cytokine Dysregulation in pulmonary Tuberculosis: The role of TNF-\u03b1\/IL-10 and TNF-\u03b1\/TGF-\u03b2 ratios as severity indicators. Hum Immunol. 2025;86(2):111256. https:\/\/doi.org\/10.1016\/j.humimm.2025.111256.","journal-title":"Hum Immunol"},{"issue":"1","key":"5051_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/hmbci-2022-0031","volume":"44","author":"BK Yadav","year":"2022","unstructured":"Yadav BK, Shah AK, Karunanand B, Sudan DS, Sharma M. Comparative evaluation of INF-\u03b3 as an immunological healing marker based on anti-tubercular treatment among diabetic and non-diabetic pulmonary tuberculosis patients. Horm Mol Biol Clin Investig. 2022;44(1):33\u20137. https:\/\/doi.org\/10.1515\/hmbci-2022-0031. Published 2022 Sep 26.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"107","key":"5051_CR39","doi-asserted-by":"publisher","first-page":"eads7377","DOI":"10.1126\/sciimmunol.ads7377","volume":"10","author":"M Ogishi","year":"2025","unstructured":"Ogishi M, Puchan J, Yang R, et al. Human LY9 governs CD4\u2009+\u2009T cell IFN-\u03b3 immunity to Mycobacterium tuberculosis. Sci Immunol. 2025;10(107):eads7377. https:\/\/doi.org\/10.1126\/sciimmunol.ads7377.","journal-title":"Sci Immunol"},{"issue":"6","key":"5051_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00284-023-03306-z","volume":"80","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhang L, Zhou C, et al. Combined Detection of IFN-\u03b3 and Lymphocyte Subsets with Activation Indicators in the Clinical Application of Mycobacterium Tuberculosis Infection at Different Times. Curr Microbiol. 2023;80(6):193. https:\/\/doi.org\/10.1007\/s00284-023-03306-z. Published 2023 Apr 27.","journal-title":"Curr Microbiol"},{"issue":"1","key":"5051_CR41","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s42003-022-04265-0","volume":"5","author":"M Ahmed","year":"2022","unstructured":"Ahmed M, Mackenzie J, Tezera L, et al. Mycobacterium tuberculosis senses host Interferon-\u03b3 via the membrane protein MmpL10. Commun Biol. 2022;5(1):1317. https:\/\/doi.org\/10.1038\/s42003-022-04265-0. Published 2022 Dec 1.","journal-title":"Commun Biol"},{"issue":"6","key":"5051_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/cid\/civ978","volume":"62","author":"S Ravimohan","year":"2016","unstructured":"Ravimohan S, Tamuhla N, Nfanyana K, et al. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4\u2009+\u2009T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. Clin Infect Dis. 2016;62(6):795\u2013803. https:\/\/doi.org\/10.1093\/cid\/civ978.","journal-title":"Clin Infect Dis"},{"key":"5051_CR43","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3389\/fimmu.2020.01671","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu X, Li F, Niu H, Corrigendum, et al. IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation. Front Immunol. 2020;11:1671. https:\/\/doi.org\/10.3389\/fimmu.2020.01671. Published 2020 Jul 31.","journal-title":"Front Immunol"},{"key":"5051_CR44","doi-asserted-by":"publisher","unstructured":"Omrani M, Ghodousi A, Cirillo DM. An integrative and comprehensive analysis of blood transcriptomes combined with machine learning models reveals key signatures for tuberculosis diagnosis and risk stratification. Front Microbiol. 2025;16:1546770. https:\/\/doi.org\/10.3389\/fmicb.2025.1546770.\u00a0 Published 26 May 2025.","DOI":"10.3389\/fmicb.2025.1546770"},{"issue":"1","key":"5051_CR45","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1038\/s41467-025-60255-w","volume":"16","author":"KL Fonseca","year":"2025","unstructured":"Fonseca KL, Lozano JJ, Despuig A, et al. Unravelling the transcriptome of the human tuberculosis lesion and its clinical implications. Nat Commun. 2025;16(1):5028. https:\/\/doi.org\/10.1038\/s41467-025-60255-w. Published 2025 May 30.","journal-title":"Nat Commun"},{"issue":"3","key":"5051_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1473-3099(20)30928-2","volume":"21","author":"LT Hoang","year":"2021","unstructured":"Hoang LT, Jain P, Pillay TD, et al. Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study. Lancet Infect Dis. 2021;21(3):366\u201375. https:\/\/doi.org\/10.1016\/S1473-3099(20)30928-2.","journal-title":"Lancet Infect Dis"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05051-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05051-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05051-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:32:03Z","timestamp":1780453923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05051-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5051"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05051-2","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Jiangxi Chest Hospital (Reference number: 202510588). The need for informed consent was waived by the Ethics Committee of Jiangxi Chest Hospital due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"522"}}